Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema

Proceedings of the National Academy of Sciences of the United States of America

Volumn 109, Issue 6, 2012, Pages 2084-2089

  Lucas, Rudolf ^a   Sridhar, Supriya ^a   Rick, Ferenc G ^b,c   Gorshkov, Boris ^a   Umapathy, Nagavedi S ^a   Yang, Guang ^a   Oseghale, Aluya ^a   Verin, Alexander D ^a   Chakraborty, Trinad ^d   Matthay, Michael A ^e   Zemskov, Evgeny A ^a   White, Richard ^a   Block, Norman L ^b,c   Schally, Andrew V ^b,c  

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b UNIVERSITY OF MIAMI   (United States)

^c UNIVERSITY OF MIAMI MILLER SCHOOL OF MEDICINE   (United States)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Cyclic AMP; Pneumonia

Indexed keywords

CYCLIC AMP; GROWTH HORMONE RELEASING FACTOR DERIVATIVE; MESSENGER RNA; MYOSIN LIGHT CHAIN; PNEUMOLYSIN; SODIUM ION; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; DRUG EFFECT; HUMAN; HUMAN CELL; HYPOTHALAMUS; LUNG ALVEOLUS EPITHELIUM; LUNG EDEMA; LUNG FLUID; MALE; MICROVASCULAR ENDOTHELIAL CELL; MONOLAYER CULTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SODIUM TRANSPORT; TRACHEA;

ANIMALS; ANTIGENS, CD; BACTERIAL PROTEINS; CADHERINS; ENDOTHELIAL CELLS; GENE EXPRESSION REGULATION; GROWTH HORMONE-RELEASING HORMONE; HUMANS; ION CHANNEL GATING; LUNG; MICE; MICE, INBRED C57BL; MICROVESSELS; MYOSIN LIGHT CHAINS; PERMEABILITY; PHOSPHORYLATION; PULMONARY ALVEOLI; PULMONARY EDEMA; RECEPTORS, NEUROPEPTIDE; RECEPTORS, PITUITARY HORMONE-REGULATING HORMONE; RNA SPLICING; SODIUM CHANNELS; STREPTOLYSINS;

BACTERIA (MICROORGANISMS); MUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84857132877     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1121075109     Document Type: Article

References (39)

1. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H (2008) Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 86:408-416. (Pubitemid 351694322)
2. Waterer GW, Rello J, Wunderink RG (2011) Management of community-acquired pneumonia in adults. Am J Respir Crit Care Med 183(2):157-164.
3. Berthiaume Y, Matthay MA (2007) Alveolar edema fluid clearance and acute lung injury. Respir Physiol Neurobiol 159:350-359. (Pubitemid 350123611)
4. Rubins JB, et al. (1996) Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med 153:1339-1346. (Pubitemid 26112601)
5. Witzenrath M, et al. (2006) Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia. Crit Care Med 34:1947-1954. (Pubitemid 43982472)
6. Maus UA, et al. (2004) Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space. J Immunol 173:1307-1312. (Pubitemid 38924309)
7. Anderson R, et al. (2007) Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother 60:1155-1158. (Pubitemid 47617770)
8. Fukuda Y, et al. (2006) Effects of macrolides on pneumolysin of macrolide-resistant Streptococcus pneumoniae. Eur Respir J 27:1020-1025. (Pubitemid 44911118)
9. Stringaris AK, et al. (2002) Neurotoxicity of pneumolysin, a major pneumococcal virulence factor, involves calcium influx and depends on activation of p38 mitogen-activated protein kinase. Neurobiol Dis 11:355-368. (Pubitemid 36269122)
10. Sandoval R, et al. (2001) Ca2+ signalling and PKCα activate increased endothelial permeability by disassembly of VE-cadherin junctions. J Physiol 533:433-445. (Pubitemid 32519999)
11. Xiong C, et al. (2010) The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells - A crucial role for protein kinase C-α inhibition. Vascul Pharmacol 52(5-6):207-213.
12. Petrache I, Birukova A, Ramirez SI, Garcia JG, Verin AD (2003) The role of the microtubules in tumor necrosis factor-α-induced endothelial cell permeability. Am J Respir Cell Mol Biol 28:574-581. (Pubitemid 36543404)
13. Ware LB, Matthay MA (2001) Alveolar fluid clearance is impaired in the majority of patients with acute lung injury and the acute respiratory distress syndrome. Am J Respir Crit Care Med 163:1376-1383. (Pubitemid 32506602)
14. Matthay MA, Robriquet L, Fang X (2005) Alveolar epithelium: Role in lung fluid balance and acute lung injury. Proc Am Thorac Soc 2(3):206-213. (Pubitemid 41500847)
15. + channel is made of three homologous subunits. Nature 367:463-467.
16. Eaton DC, Malik B, Bao HF, Yu L, Jain L (2010) Regulation of epithelial sodium channel trafficking by ubiquitination. Proc Am Thorac Soc 7(1):54-64.
17. Vadász I, Raviv S, Sznajder JI (2007) Alveolar epithelium and Na,K-ATPase in acute lung injury. Intensive Care Med 33:1243-1251. (Pubitemid 47036896)
18. Mayo KE, Godfrey PA, Suhr ST, Kulik DJ, Rahal JO (1995) Growth hormone-releasing hormone: Synthesis and signaling. Recent Prog Horm Res 50:35-73.
19. Schally AV, Varga JL, Engel JB (2008) Antagonists of growth-hormone- releasing hormone: An emerging new therapy for cancer. Nat Clin Pract Endocrinol Metab 4(1): 33-43. (Pubitemid 350291102)
20. Kiaris H, Chatzistamou I, Papavassiliou AG, Schally AV (2011) Growth hormone-releasing hormone: Not only a neurohormone. Trends Endocrinol Metab 22:311-317.
21. Rekasi Z, Czompoly T, Schally AV, Halmos G (2000) Isolation and sequencing of cDNAs for splice variants of growth hormone-releasing hormone receptors from human cancers. Proc Natl Acad Sci USA 97:10561-10566.
22. Kanashiro-Takeuchi RM, et al. (2010) Cardioprotective effects of growth hormone-releasing hormone agonist after myocardial infarction. Proc Natl Acad Sci USA 107: 2604-2609.
23. Ludwig B, et al. (2010) Agonist of growth hormone-releasing hormone as a potential effector for survival and proliferation of pancreatic islets. Proc Natl Acad Sci USA 107: 12623-12628.
24. Dioufa N, et al. (2010) Acceleration of wound healing by growth hormone-releasing hormone and its agonists. Proc Natl Acad Sci USA 107:18611-18615.
25. Granata R, et al. (2009) Growth hormone-releasing hormone promotes survival of cardiac myocytes in vitro and protects against ischaemia-reperfusion injury in rat heart. Cardiovasc Res 83:303-312.
26. Izdebski J, et al. (1995) Synthesis and biological evaluation of superactive agonists of growth hormone-releasing hormone. Proc Natl Acad Sci USA 92:4872-4876.
27. Andriopoulou P, Navarro P, Zanetti A, Lampugnani MG, Dejana E (1999) Histamine induces tyrosine phosphorylation of endothelial cell-to-cell adherens junctions. Arterioscler Thromb Vasc Biol 19:2286-2297. (Pubitemid 29477828)
28. Dejana E, Orsenigo F, Lampugnani MG (2008) The role of adherens junctions and VE-cadherin in the control of vascular permeability. J Cell Sci 121:2115-2122.
29. Hatanaka K, Simons M, Murakami M (2011) Phosphorylation of VE-cadherin controls endothelial phenotypes via p120-catenin coupling and Rac1 activation. Am J Physiol Heart Circ Physiol 300:H162-H172.
30. Pozsgai E, et al. (2011) The effect of a novel antagonist of growth hormone releasing hormone on cell proliferation and on the key cell signaling pathways in nine different breast cancer cell lines. Int J Oncol 39:1025-1032.
31. Lazrak A, Matalon S (2003) cAMP-induced changes of apical membrane potentials of confluent H441 monolayers. Am J Physiol Lung Cell Mol Physiol 285:L443-L450. (Pubitemid 36909461)
32. Lawrence DW, Comerford KM, Colgan SP (2002) Role of VASP in reestablishment of epithelial tight junction assembly after Ca2+ switch. Am J Physiol Cell Physiol 282: C1235-C1245. (Pubitemid 34663071)
33. Fukuhara S, et al. (2005) Cyclic AMP potentiates vascular endothelial cadherin-mediated cell-cell contact to enhance endothelial barrier function through an Epac-Rap1 signaling pathway. Mol Cell Biol 25(1):136-146. (Pubitemid 40039806)
34. Qiao J, et al. (2008) Phosphorylation of GTP dissociation inhibitor by PKA negatively regulates RhoA. Am J Physiol Cell Physiol 295:C1161-C1168. (Pubitemid 352790336)
35. Umapathy NS, et al. (2010) Extracellular β-nicotinamide adenine dinucleotide (β-NAD) promotes the endothelial cell barrier integrity via PKA- and EPAC1/Rac1-dependent actin cytoskeleton rearrangement. J Cell Physiol 223(1):215-223.
36. Chen XJ, et al. (2004) Influenza virus inhibits ENaC and lung fluid clearance. Am J Physiol Lung Cell Mol Physiol 287:L366-L373.
37. Mustafa SB, et al. (2008) Protein kinase A and mitogen-activated protein kinase pathways mediate cAMP induction of α-epithelial Na+ channels (α-ENaC). J Cell Physiol 215(1):101-110. (Pubitemid 351363195)
38. Fang X, Song Y, Zemans R, Hirsch J, Matthay MA (2004) Fluid transport across cultured rat alveolar epithelial cells: A novel in vitro system. Am J Physiol Lung Cell Mol Physiol 287:L104-L110. (Pubitemid 38787656)
39. Moitra J, Sammani S, Garcia JG (2007) Re-evaluation of Evans Blue dye as a marker of albumin clearance in murine models of acute lung injury. Transl Res 150(4):253-265. (Pubitemid 47444609)